Overview

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate an investigational medication to treat chronic asthma. The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years. Participants in the study will have a number of visits to a research site over an 8-month period. All study-related care and medication is provided to qualified participants at no cost. This includes all visits, examinations and laboratory work.
Phase:
Phase 2
Details
Lead Sponsor:
Facet Biotech
Treatments:
Antibodies
Antibodies, Monoclonal
Immunoglobulins